Kenneth P. Nephew
Biochemistry, Genetics and Molecular Biology · Indiana University
Publications
500
Citations
15,900
Est. group size
—
Recurring co-author estimate
Active years
39
Publishing since 1988
Kenneth P. Nephew studies the molecular and genetic basis of cancer, with a particular focus on ovarian and breast cancers. His work examines how epigenetics (chemical changes that turn genes on or off without altering DNA sequence), DNA methylation, and gene-regulating molecules like microRNAs drive tumor growth, drug resistance, and cancer stem-like cells. He also investigates therapeutic strategies, such as combining drugs that target these molecular pathways.
Publication activity has been steady with notable spikes in recent years, averaging around 40 outputs per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Extracellular vesicles facilitate the horizontal transfer of drug resistance and stem-like properties between ovarian tumor cells
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- Not All STICs Are Equal: Unraveling the Implications of Precursor Heterogeneity
Cancer Research · 2026
- Rethinking ovarian cancer III: the past decade and future directions
Nature reviews. Cancer · 2026
- Rethinking ovarian cancer III: the past decade and future directions.
Apollo (University of Cambridge) · 2026
- Abstract 2245: DNMTi in combination with PARPi inhibits aberrant Wnt/β-catenin signaling and tenasin-C pathways, cancer stemness and metastasis in triple negative breast cancer.
Cancer Research · 2026
- Abstract PR001: ZNFX1 is a master regulator and tumor suppressor in epigenetically-induced pathogen mimicry, mitochondrial dysfunction and STING-dependent signaling in cancer
Cancer Research · 2025
- Figure 4 from Claudin-4 Stabilizes the Genome via Nuclear and Cell-Cycle Remodeling to Support Ovarian Cancer Cell Survival
2025
- Figure 7 from Claudin-4 Stabilizes the Genome via Nuclear and Cell-Cycle Remodeling to Support Ovarian Cancer Cell Survival
2025
- Supplementary Figure 3 from Claudin-4 Stabilizes the Genome via Nuclear and Cell-Cycle Remodeling to Support Ovarian Cancer Cell Survival
2025
- Supplementary Figure 1 from Claudin-4 Stabilizes the Genome via Nuclear and Cell-Cycle Remodeling to Support Ovarian Cancer Cell Survival
2025
- Data from Claudin-4 Stabilizes the Genome via Nuclear and Cell-Cycle Remodeling to Support Ovarian Cancer Cell Survival
2025
- Figure 6 from Claudin-4 Stabilizes the Genome via Nuclear and Cell-Cycle Remodeling to Support Ovarian Cancer Cell Survival
2025
- Supplementary Figure 6 from Claudin-4 Stabilizes the Genome via Nuclear and Cell-Cycle Remodeling to Support Ovarian Cancer Cell Survival
2025
- Supplementary Figure 5 from Claudin-4 Stabilizes the Genome via Nuclear and Cell-Cycle Remodeling to Support Ovarian Cancer Cell Survival
2025
- Supplementary Figure 4 from Claudin-4 Stabilizes the Genome via Nuclear and Cell-Cycle Remodeling to Support Ovarian Cancer Cell Survival
2025
- Cancer Research×50
- bioRxiv (Cold Spring Harbor Laboratory)×17
- Clinical Cancer Research×14
- PMC×13
- Cancers×6
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile